Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Eywa Pharma

Explore full profile

Develops generic pharma products based on robust technologies

Singapore, SingaporeFounded 2015Biotech & Life Sciences
Valuation $100–250M Last recorded · 2016
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Eywa Pharma and the history behind them.

About Eywa Pharma

Eywa Pharma is a rapidly growing global generic pharmaceuticals company dedicated to providing affordable, high-quality medicines to patients worldwide. The company addresses critical challenges such as aging populations, rising healthcare costs, supply interruptions, and accessibility to essential medications. Eywa Pharma serves a diverse range of clients, including healthcare providers, pharmacies, and distributors, operating primarily in the generic pharmaceuticals market. The business model focuses on the development, manufacturing, and distribution of generic drugs, ensuring continuous access to essential medicines at competitive prices. Revenue is generated through the sale of these generic pharmaceuticals across various international markets. Eywa Pharma's seasoned team, with deep industry experience, is passionately committed to the company's mission of making high-quality medicines available globally.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2015
Headquarters
Singapore, Singapore
Employees
24
Open positions
None listed
Dealroom signal
61.2/100
Industry
Health
Sub-industry
Pharmaceutical
Sector
Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
b2b, b2c

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
EARLY VCEquity / VC Jan 2019 $0 — InnoVen Capital —
SERIES A✓Equity / VC Oct 2016 $30M $120M Eight Roads Ventures · F-Prime · Envest Capital Partners · Fidelity International Strategic Ventures —
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Eywa Pharma website traffic

Latest recorded traffic for Eywa Pharma is 650 monthly website visits, up 282.4% over the last three months. Eywa Pharma's team declined 7.7% over the past year.

Latest monthly visits650 3-month web change+282.4% 1-year team growth-7.7%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A5 investors entered at this stage

Team profiled 3 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇮🇳 India86.7%
🇺🇸 United States13.3%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Eywa Pharma on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Eywa Pharma’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.